TickerFacts.

Charles River Laboratories International, Inc. (CRL): Share Repurchases

Annual figures by period end, from SEC filings.

$360.67M
Year ended 2025-12-27
$324.07M
Trailing 12 months to 2026-06-27
+110.5%
3-year compound annual growth
+72.0%
5-year compound annual growth
+11.9%
10-year compound annual growth
2008-12-27: $115.06M2009-12-26: $45.90M2010-12-25: $356.53M2011-12-31: $283.80M2012-12-29: $64.19M2013-12-28: $165.93M2014-12-27: $122.02M2015-12-26: $117.48M2016-12-31: $12.27M2017-12-30: $106.91M2018-12-29: $13.85M2019-12-28: $18.09M2020-12-26: $23.98M2021-12-25: $40.71M2022-12-31: $38.65M2023-12-30: $24.16M2024-12-28: $119.17M2025-12-27: $360.67M$360.67M
2008-12-27 Share Repurchases (USD) 2025-12-27
Period endedShare RepurchasesChange YoYSource filing
2025-12-27$360.67M+202.6%2026-02-18, From 2024-12-29
2024-12-28$119.17M+393.4%2026-02-18, From 2023-12-31
2023-12-30$24.16M-37.5%2026-02-18, From 2023-01-01
2022-12-31$38.65M-5.1%2025-02-19, From 2021-12-26
2021-12-25$40.71M+69.8%2024-02-14, From 2020-12-27
2020-12-26$23.98M+32.6%2023-02-22, From 2019-12-29
2019-12-28$18.09M+30.6%2022-02-16, From 2018-12-30
2018-12-29$13.85M-87.0%2021-02-17, From 2017-12-31
2017-12-30$106.91M+771.5%2020-02-11, From 2017-01-01
2016-12-31$12.27M-89.6%2019-02-13, From 2015-12-27
2015-12-26$117.48M-3.7%2018-02-13, From 2014-12-28
2014-12-27$122.02M-26.5%2017-02-14, From 2013-12-29
2013-12-28$165.93M+158.5%2016-02-12, From 2012-12-30
2012-12-29$64.19M-77.4%2015-02-17, From 2012-01-01
2011-12-31$283.80M-20.4%2014-02-25, From 2010-12-26
2010-12-25$356.53M+676.8%2013-02-27, From 2009-12-27
2009-12-26$45.90M-60.1%2012-02-27, From 2008-12-28
2008-12-27$115.06Mn/a2011-02-23, From 2007-12-30

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Charles River Laboratories International, Inc. (CRL)2025-12-27$360.67M+202.6%
Incyte Corp (INCY)2025-12-31$0-100.0%
Medpace Holdings, Inc. (MEDP)2025-12-31$917.39M+440.1%
Icon PLC (ICLR)2025-12-31$750.00M+50.0%
Iqvia Holdings Inc. (IQV)2025-12-31$1.24B-7.9%
NRC Health (NRC)2025-12-31$20.18M-34.8%
IB Acquisition Corp. (IBAC)2025-09-30$106.13Mn/a

Compare CRL, INCY, MEDP, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗